#USA #Veeva Systems #Barcelona #Clinical Trials #Amgen

Veeva and Amgen Join Forces to Transform Clinical Trials

Veeva Systems Inc. (NYSE: VEEV) recently announced a strategic partnership with Amgen, a prominent global biotechnology firm, to enhance innovations in the realm of clinical trials. This collaboration aims to harness advanced technologies, thereby increasing efficiency across the entire clinical trial process.

Amgen, recognized as a leader in developing groundbreaking medications for serious diseases, is set to implement the Veeva Clinical Platform to streamline their clinical operations. Scott Skellenger, Senior Vice President and Chief Information Officer at Amgen, stated, "Through our partnership with Veeva, we will utilize state-of-the-art technologies to unlock new possibilities for our end-to-end study processes, ultimately reinforcing our ability to deliver innovative treatments to patients quickly and at scale."

Jim Reilly, President of Veeva Development Cloud, expressed enthusiasm about this partnership, stating, "We are excited to support Amgen in advancing clinical development. The Veeva Clinical Platform will serve as the foundation for standardized and interconnected processes that can dramatically speed up the delivery of life-saving medications to patients in need."

The collaboration involves Veeva Business Consulting providing support to Amgen in managing implementation and change management to ensure a smooth transition and maximize efficiency.

Insights on Veeva Clinical Platform

The Veeva Clinical Platform is a comprehensive and connected suite for clinical operations and data applications. This end-to-end platform includes features like Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Clinical Workbench (CDB), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessments (eCOA), Electronic Trial Master Files (eTMF), Site Connect, Study Training, and more. By utilizing interconnected products, clinical trials can be streamlined from initiation to completion, automating an integrated data flow and paving the way for rapid innovation in drug development.

For further information, you can visit Veeva Clinical Platform.

About Veeva Systems

Veeva is a prominent player in providing cloud solutions for the life sciences sector, combining software, data, and consulting services. The company is dedicated to fostering innovation, ensuring product quality, and achieving customer success, serving over 1,500 clients ranging from the world’s largest biopharmaceutical companies to emerging biotech enterprises. As a Public Benefit Corporation, Veeva strives to balance the interests of all stakeholders, including customers, employees, shareholders, and the communities in which it operates.

Learn more about Veeva on their official website.

Future Outlook

This announcement contains forward-looking statements regarding the products and services offered by Veeva as well as the anticipated outcomes or benefits of utilizing these solutions. These statements are based on current expectations, and actual results may differ significantly from those expressed or implied in this communication. Veeva cautions about various risks that may negatively impact its outcomes, which are detailed in the company’s Form 10-Q for the quarter ended April 30, 2025. This form can be accessed on the SEC’s website for a comprehensive overview of the potential risks.

For media inquiries, please contact:
Jeremy Whittaker
Veeva Systems
Phone: +49-695-095-5486
Email: [email protected]